𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Caspase activity is essential for long-term potentiation

✍ Scribed by Natalia V. Gulyaeva; Igor E. Kudryashov; Irina V. Kudryashova


Book ID
102383425
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
162 KB
Volume
73
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Slices from rat hippocampus were incubated with the caspase‐3 inhibitor N‐benzyloxycarbonyl‐Asp‐Glu‐Val‐Asp fluoromethylketone (Z‐DEVD‐FMK) or with the inactive peptide N‐benzyloxycarbonyl‐Phe‐Ala fluoromethylketone (Z‐Phe‐Ala‐FMK) for 30 min. The peptides changed neither input–output curves nor paired‐pulse effects at 70‐msec interpulse intervals, nor amplitudes of pop spikes in the CA1 region 1.0–6.9 hr after the incubation. Slices taken 1.0–1.4 hr after Z‐DEVD‐FMK or inactive peptide treatment demonstrated similar long‐term potentiation (LTP) curves; however, LTP was suppressed significantly (P < 0.001) 1.5–3.4 hr after Z‐DEVD‐FMK treatment when compared to the corresponding inactive peptide group. LTP magnitude correlated with time after Z‐DEVD‐FMK (r = −0.74; P < 0.02) but did not depend on time after the inactive peptide treatment. After 3.5 hr, LTP was blocked completely. Z‐DEVD‐FMK did not have a significant effect on presynaptic function. The results are the first evidence that inhibition of caspase‐3 significantly decreases or fully blocks LTP in the CA1 region and suggest that caspase‐3 is essential for LTP. Candidate caspase‐3 substrates that may be cleaved for LTP induction and maintenance are discussed. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


A critical level of protein synthesis is
✍ Sam A. Deadwyler; Tom Dunwiddie; Gary Lynch 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Long-term potentiation (LTP) of the hippocampal population spike in area CA1 was studied in the hippocampal slice before, during, and after inhibition of protein synthesis. LTP was tested 15 and 30 min following addition of the protein synthesis inhibitor cycloheximide (CXM) to the bathing medium. S